These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10792759)

  • 21. Pharmacology review: the role of ondansetron in the management of children's nausea and vomiting following posterior fossa neurosurgical procedures.
    Neufeld S
    Axone; 2002 Jun; 23(4):24-9. PubMed ID: 12085394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient blindness following intravenous ondansetron.
    Cherian A; Maguire M
    Anaesthesia; 2005 Sep; 60(9):938-9. PubMed ID: 16115266
    [No Abstract]   [Full Text] [Related]  

  • 23. Ondansetron after Caesarian section.
    Sanai L
    Br J Anaesth; 2001 Dec; 87(6):942-3; author reply 943. PubMed ID: 11878706
    [No Abstract]   [Full Text] [Related]  

  • 24. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of oral ondansetron disintegrating tablets for prevention of at-home emesis in pediatric patients after ear-nose-throat surgery.
    Davis PJ; Fertal KM; Boretsky KR; Fedel GM; Ingram MD; Woelfel SK; Hoffmann PC; Gurnaney H; Young MC
    Anesth Analg; 2008 Apr; 106(4):1117-21, table of contents. PubMed ID: 18349181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.
    Shi Y; He X; Yang S; Ai B; Zhang C; Huang D; Dong M; Liu P; Zhou S; Han X
    Chemotherapy; 2007; 53(1):44-50. PubMed ID: 17202811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychiatric complications associated with ondansetron.
    Mitchell KE; Popkin MK; Trick W; Vercellotti G
    Psychosomatics; 1994; 35(2):161-3. PubMed ID: 8171176
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute postoperative pancreatitis, is it associated with the use of ondansetron?].
    Granados LM; Ballester F; Suárez F; Sánchez-Peña J; Navas E
    Rev Esp Anestesiol Reanim; 1997 Feb; 44(2):87. PubMed ID: 9148363
    [No Abstract]   [Full Text] [Related]  

  • 30. Ondansetron oral disintegrating tablets: acceptability and efficacy in children undergoing adenotonsillectomy.
    Cohen IT; Joffe D; Hummer K; Soluri A
    Anesth Analg; 2005 Jul; 101(1):59-63, table of contents. PubMed ID: 15976206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    ; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
    J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy.
    Bloch J; Rixe O; Meric JB; Delgado A; Khayat D
    Curr Med Res Opin; 2005 Nov; 21(11):1763-71. PubMed ID: 16307696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ondansetron and chest pain.
    Lee J
    Emerg Med J; 2005 Jan; 22(1):78. PubMed ID: 15611556
    [No Abstract]   [Full Text] [Related]  

  • 34. QT prolongation with the use of ondansetron: A neglected and overlooked adverse effect.
    Hussain D
    J Pak Med Assoc; 2024 May; 74(5):1013. PubMed ID: 38783462
    [No Abstract]   [Full Text] [Related]  

  • 35. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
    Abali H; Celik I
    Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contextualizing Potential Risks of Medications in Pregnancy for the Newborn-the Case of Ondansetron.
    Huybrechts KF; Hernández-Díaz S; Bateman BT
    JAMA Pediatr; 2020 Aug; 174(8):747-748. PubMed ID: 32478805
    [No Abstract]   [Full Text] [Related]  

  • 37. Ondansetron-induced extrapyramidal symptoms during cesarean section.
    Spiegel JE; Kang V; Kunze L; Hess P
    Int J Obstet Anesth; 2005 Oct; 14(4):368-9. PubMed ID: 16154341
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous ondansetron causing severe bradycardia: two cases.
    Afonso N; Dang A; Namshikar V; Kamat S; Rataboli PV
    Ann Card Anaesth; 2009; 12(2):172-3. PubMed ID: 19602754
    [No Abstract]   [Full Text] [Related]  

  • 39. Anaphylaxis to an ondansetron wafer.
    Tan J; Mehr S
    J Paediatr Child Health; 2012 Jun; 48(6):543-4. PubMed ID: 21679335
    [No Abstract]   [Full Text] [Related]  

  • 40. Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.
    Ismail S; Funk MJ; Flythe JE
    J Am Soc Nephrol; 2024 Jun; 35(6):761-771. PubMed ID: 38409683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.